• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-10(-1082)启动子单核苷酸多态性对丙型肝炎病毒4型感染结局的影响

Impact of IL-10 (-1082) promoter-single nucleotide polymorphism on the outcome of hepatitis C virus genotype 4 infection.

作者信息

Helal Soheir F, Gomaa Howayda E, Thabet Eman H, Younan Mariam A, Helmy Neveen A

机构信息

Virology and Clinical Pathology Department, Cairo University, Egypt.

Clinical and Chemical Pathology Department, National Research Centre, Cairo, Egypt.

出版信息

Clin Med Insights Gastroenterol. 2014 Apr 1;7:19-24. doi: 10.4137/CGast.S13658. eCollection 2014.

DOI:10.4137/CGast.S13658
PMID:24833945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4019231/
Abstract

UNLABELLED

Immunoregulatory cytokines may influence the hepatitis C virus (HCV) infection outcome. This study aimed to determine the genotypic and allelic frequencies of the interleukin (IL)-10 (-1082) G/A polymorphism, and its association with chronicity or resolution of HCV genotype 4 infection in Egypt. The frequencies of different dimorphic polymorphisms based on single nucleotide substitution in chronic HCV patients (50) and resolved HCV patients (50) were: IL-10 (-1082) G/G 22 (44%) and 18 (36%), G/A 19 (38%) and 24 (48%), and A/A 9 (18%), and 8 (16%), respectively. In the sustained virologic response (SVR) (36) and spontaneously resolved subjects (14) groups, the frequencies were: IL-10 (-1082) G/G 11 (30.6%) and 7 (50%) G/A 18 (50%) and 6 (42.9%), A/A 7 (19.4%) and 1 (7.1%), respectively. An association between male gender and chronic hepatitis C outcome (P value 0.041) was found. However, no significant gender difference was found when we compared females versus males with elevated alanine transaminase (ALT) levels in the chronic HCV patient group (P value = 1).

CONCLUSION

No significant difference in the frequency of IL-10 single nucleotide polymorphism (SNP) at position 1082 was found between chronic and resolved HCV subjects.

摘要

未标记

免疫调节细胞因子可能影响丙型肝炎病毒(HCV)感染的结果。本研究旨在确定白细胞介素(IL)-10(-1082)G/A多态性的基因型和等位基因频率,及其与埃及HCV 4型感染的慢性化或痊愈的关联。慢性HCV患者(50例)和痊愈HCV患者(50例)中基于单核苷酸替换的不同双态多态性频率分别为:IL-10(-1082)G/G 22例(44%)和18例(36%),G/A 19例(38%)和24例(48%),以及A/A 9例(18%)和8例(16%)。在持续病毒学应答(SVR)组(36例)和自发痊愈组(14例)中,频率分别为:IL-10(-1082)G/G 11例(30.6%)和7例(50%),G/A 18例(50%)和6例(42.9%),A/A 7例(19.4%)和1例(7.1%)。发现男性性别与慢性丙型肝炎结局之间存在关联(P值0.041)。然而,在慢性HCV患者组中比较丙氨酸转氨酶(ALT)水平升高的女性和男性时,未发现显著的性别差异(P值 = 1)。

结论

慢性和痊愈的HCV受试者之间在1082位的IL-10单核苷酸多态性(SNP)频率上未发现显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e037/4019231/a3d64d2e545f/cgast-7-2014-019f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e037/4019231/5ef8c4a33646/cgast-7-2014-019f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e037/4019231/a3d64d2e545f/cgast-7-2014-019f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e037/4019231/5ef8c4a33646/cgast-7-2014-019f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e037/4019231/a3d64d2e545f/cgast-7-2014-019f2.jpg

相似文献

1
Impact of IL-10 (-1082) promoter-single nucleotide polymorphism on the outcome of hepatitis C virus genotype 4 infection.白细胞介素-10(-1082)启动子单核苷酸多态性对丙型肝炎病毒4型感染结局的影响
Clin Med Insights Gastroenterol. 2014 Apr 1;7:19-24. doi: 10.4137/CGast.S13658. eCollection 2014.
2
Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3.细胞因子基因多态性对慢性丙型肝炎基因3型患者组织学活性指数、病毒载量及治疗反应的影响
World J Gastroenterol. 2005 Nov 14;11(42):6656-61. doi: 10.3748/wjg.v11.i42.6656.
3
IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients.台湾慢性丙型肝炎患者白细胞介素-10启动子基因多态性与联合治疗的持续应答
Dig Liver Dis. 2009 Jun;41(6):424-30. doi: 10.1016/j.dld.2008.09.017. Epub 2008 Nov 11.
4
Association of Interleukin-27 rs 153109 Single Nucleotide Polymorphism with Spontaneous Resolution of Hepatitis C Virus - Genotype 4a Infection in Egyptian Patients.白细胞介素-27 rs153109单核苷酸多态性与埃及患者丙型肝炎病毒4a基因型感染自发清除的相关性
Asian Pac J Cancer Prev. 2016;17(4):2093-7. doi: 10.7314/apjcp.2016.17.4.2093.
5
Prevalence of rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.rs4803217单核苷酸多态性的患病率与慢性丙型肝炎的临床病程
World J Gastroenterol. 2017 Jun 7;23(21):3815-3824. doi: 10.3748/wjg.v23.i21.3815.
6
[Association of IL-10-1082 and IL-10-592 polymorphisms with chronic hepatitis B and/or hepatitis C virus infection among plasma donors in a rural area of Hebei Province, China].[中国河北省农村地区献血者中白细胞介素-10基因-1082和-592多态性与慢性乙型肝炎和/或丙型肝炎病毒感染的相关性]
Wei Sheng Yan Jiu. 2011 Nov;40(6):709-13.
7
The complete title: The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C.完整标题:白细胞介素-28B rs12979860基因多态性对摩洛哥慢性丙型肝炎患者治疗反应的影响
Gene. 2015 Aug 15;568(1):31-4. doi: 10.1016/j.gene.2015.05.010. Epub 2015 May 7.
8
Interleukin-12B gene polymorphism frequencies in Egyptians and sex-related susceptibility to hepatitis C infection.白细胞介素 12B 基因多态性频率在埃及人和性别相关的丙型肝炎感染易感性中的研究。
J Interferon Cytokine Res. 2013 Aug;33(8):415-9. doi: 10.1089/jir.2012.0161. Epub 2013 Apr 19.
9
[Relations between IL-2-330 polymorphisms and the outcome of hepatitis B and/or hepatitis C virus infection].[白细胞介素-2 - 330多态性与乙型和/或丙型肝炎病毒感染结局的关系]
Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Sep;31(9):1041-5.
10
Impact of IL12B gene rs 3212227 polymorphism on fibrosis, liver inflammation, and response to treatment in genotype 4 Egyptian hepatitis C patients.IL12B 基因 rs3212227 多态性对基因型 4 埃及丙型肝炎患者纤维化、肝炎症和治疗反应的影响。
Dis Markers. 2013;35(5):431-7. doi: 10.1155/2013/627589. Epub 2013 Oct 1.

引用本文的文献

1
Impact of IL-10 gene promoter polymorphisms on treatment response in HCV patients: A systematic review, a meta-analysis, and a meta-regression.IL-10 基因启动子多态性对 HCV 患者治疗反应的影响:系统评价、荟萃分析和荟萃回归。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241240705. doi: 10.1177/03946320241240705.

本文引用的文献

1
Cytokines genes polymorphisms in chronic hepatitis C: impact on susceptibility to infection and response to therapy.细胞因子基因多态性与慢性丙型肝炎:对感染易感性和治疗反应的影响。
Cytokine. 2013 Feb;61(2):478-84. doi: 10.1016/j.cyto.2012.11.003. Epub 2012 Dec 3.
2
Is interleukin-10 gene polymorphism a predictive marker in HCV infection?白细胞介素-10 基因多态性是否可作为 HCV 感染的预测标志物?
Cytokine Growth Factor Rev. 2012 Feb-Apr;23(1-2):47-59. doi: 10.1016/j.cytogfr.2012.01.005. Epub 2012 Mar 4.
3
Allele polymorphisms of interleukin-10 and hepatitis B, C virus infection.
白细胞介素-10 基因多态性与乙型、丙型肝炎病毒感染。
Chin Med J (Engl). 2010 May 20;123(10):1338-44.
4
Polymorphisms of some cytokines and chronic hepatitis B and C virus infection.某些细胞因子的多态性与慢性乙型和丙型肝炎病毒感染。
World J Gastroenterol. 2009 Nov 28;15(44):5610-9. doi: 10.3748/wjg.15.5610.
5
A polymorphism in the CTGF promoter region associated with systemic sclerosis.与系统性硬化症相关的结缔组织生长因子(CTGF)启动子区域的多态性。
N Engl J Med. 2007 Sep 20;357(12):1210-20. doi: 10.1056/NEJMoa067655.
6
Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism.与白细胞介素10启动子多态性相关的慢性丙型肝炎病毒感染的性别易感性。
J Virol. 2006 Sep;80(18):9144-50. doi: 10.1128/JVI.00339-06.
7
Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan.白细胞介素-10或肿瘤坏死因子-α基因多态性与日本高流行地区丙型肝炎病毒感染的自然病程
Cytokine. 2006 Apr;34(1-2):24-31. doi: 10.1016/j.cyto.2006.03.011. Epub 2006 May 15.
8
The natural history of hepatitis C virus (HCV) infection.丙型肝炎病毒(HCV)感染的自然史。
Int J Med Sci. 2006;3(2):47-52. doi: 10.7150/ijms.3.47. Epub 2006 Apr 1.
9
Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy.对接受各种基于干扰素的抗病毒治疗并获得持续病毒学应答的慢性丙型肝炎患者的长期随访。
Aliment Pharmacol Ther. 2006 Feb 15;23(4):507-11. doi: 10.1111/j.1365-2036.2006.02785.x.
10
Cellular immune responses against hepatitis C virus.针对丙型肝炎病毒的细胞免疫反应。
Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S25-31. doi: 10.1086/429492.